Company page

Alkermes Plc

Alkermes Plc (Ticker: ALKS) is a public company based in America, with a market capitalization of approximately $8.82 billion. The company focuses on developing innovative medicines for patients with serious mental health conditions and addiction. Alkermes is committed to improving patient outcomes through its research and development efforts.